Company / Cash per Share
Zimmer Biomet Cash per Share History
FY2016-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Cash per Share
$2.82
FY2025
5-year range
$1.81 / $2.82
FY2021-FY2025
Trend
+13.0%
vs FY2024
Sector context
#79 of 146
Health Care
What the data says
At $2.82, Zimmer Biomet's cash per share ranks #79 of 146 in the Health Care sector. Cash per Share has increased for 3 consecutive years, from $1.81 in FY2022 to $2.82 in FY2025.
Based on SEC 10-K filings.
2.82 in FY2025 with a 5-year CAGR of -6.5%.
Improved from $1.98 to $2.82 over the past 2 years.
Health Care sector context is included.
Cash per Share over time
Growth rates
- 3-Year CAGR
- +15.9%
- 5-Year CAGR
- -6.5%
- 10-Year CAGR
- -
Sector benchmark
#79 of 146 in Health CareTop 54% of 146This company $2.82 Sector average $27.73
▼
-89.8% below sector average
Key checks
Key Insights
- Zimmer Biomet's cash per share has grown for 3 consecutive years.
- In FY2025, cash per share increased 13.0% year-over-year.
- Ranks #79 out of 146 companies in the Health Care sector.
- Peak cash per share was recorded in FY2016.
Company context
Key Data Points
- High earnings quality (cash-backed earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Cash per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $2.82 | +13.0% |
| FY2024 | $2.50 | +26.4% |
| FY2023 | $1.98 | +8.9% |
| FY2022 | $1.81 | -0.8% |
| FY2021 | $1.83 | -53.6% |
| FY2020 | $3.94 | +29.9% |
| FY2019 | $3.03 | +13.1% |
| FY2018 | $2.68 | -2.9% |
| FY2017 | $2.76 | -56.2% |
| FY2016 | $6.31 | -25.7% |
As of FY2025 · SEC 10-K · Updated Jun 30, 2026